GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xcell Therapeutics Inc (XKRX:373110) » Definitions » Notes Receivable

Xcell Therapeutics (XKRX:373110) Notes Receivable : ₩0 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Xcell Therapeutics Notes Receivable?

Xcell Therapeutics's Notes Receivable for the quarter that ended in Dec. 2024 was ₩0 Mil.


Xcell Therapeutics Notes Receivable Historical Data

The historical data trend for Xcell Therapeutics's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xcell Therapeutics Notes Receivable Chart

Xcell Therapeutics Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Notes Receivable
Get a 7-Day Free Trial - - - - -

Xcell Therapeutics Quarterly Data
Dec19 Dec20 Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Xcell Therapeutics Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Xcell Therapeutics Notes Receivable Related Terms

Thank you for viewing the detailed overview of Xcell Therapeutics's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Xcell Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
333, Yeongdong-daero, Gangnam-gu, Seoul, KOR, 06188
Xcell Therapeutics Inc operates as a research company engaged in development of regenerative medicines. The company is developing proliferation media for various animal cell types.

Xcell Therapeutics Headlines

No Headlines